Latest news

Birmingham cancer project enters Immuno-oncology Alliance

Birmingham cancer project enters Immuno-oncology Alliance
Description
Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
Date:
29/07/2021

Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells

Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells
Description
A new study carried out in collaboration with the University of Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses.
Date:
23/07/2021

Partnership will create the next generation of researchers to transform global healthcare

Partnership will create the next generation of researchers to transform global healthcare
Description
The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
Date:
13/07/2021

Cancer Research UK Advanced Clinician Scientist shares top tips on undertaking research

Description
Dr Shishir Shetty is a Cancer Research UK Advanced Clinician Scientist and principal investigator in the Centre for Liver and Gastrointestinal Research.
Date:
07/07/2021

Congress focuses on impact of COVID-19 on global liver disease

Congress focuses on impact of COVID-19 on global liver disease
Description
University of Birmingham experts are among the leading liver disease researchers gathering at the virtual 2021 International Liver Congress to discuss the impact of the COVID-19 pandemic on people with liver disease.
Date:
25/06/2021

Fighting the silent pandemic of anti-microbial resistance

Fighting the silent pandemic of anti-microbial resistance
Description
An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.
Date:
11/06/2021

Study of UK dental professionals reveals extent of occupational risk of SARS-CoV-2 infection

Study of UK dental professionals reveals extent of occupational risk of SARS-CoV-2 infection
Description
A University of Birmingham-led study of over a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during the first wave of the pandemic in the UK.
Date:
04/06/2021

Many patients with COVID-19 produce immune responses against their body's own tissues or organs, finds study

Many patients with COVID-19 produce immune responses against their body's own tissues or organs, finds study
Description
A University of Birmingham-led study funded by the UK Coronavirus Immunology Consortium has found that many patients with COVID-19 produce immune responses against their body's own tissues or organs.
Date:
04/06/2021

Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study

Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study
Description
New study finds that antibody response in people over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to at a three-week interval.
Date:
14/05/2021

Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies

Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies
Description
A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
Date:
12/05/2021
Displaying 1 to 10 of 136
Previous 1 2 3 4 5 Next